Difference between revisions of "COVID-19 in Diabetics"

Jump to: navigation, search
(Created page with "{{SI}} {{CMG}} ==Overview== ==Historical Perspective== *[Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [eve...")
 
Line 4: Line 4:
 
==Historical Perspective==
 
==Historical Perspective==
  
*[Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
+
*On March 12, 2020, the [[World Health Organization]] declared the [[COVID-19]] outbreak a [[pandemic]].
 +
*[[Diabetes mellitus]], specifically [[Diabetes mellitus type 2|type 2 diabetes]] has been recognized as one of the most common [[Comorbidity|comorbidities]] of [[COVID-19]], caused by [[SARS-CoV-2|severe acute respiratory syndrome coronavirus-2]] ([[SARS-CoV-2]]). It has been estimated that 20-25% of patients with [[COVID-19]] had diabetes.<ref name="pmid323346462">{{cite journal| author=Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL | display-authors=etal| title=Practical recommendations for the management of diabetes in patients with COVID-19. | journal=Lancet Diabetes Endocrinol | year= 2020 | volume= 8 | issue= 6 | pages= 546-550 | pmid=32334646 | doi=10.1016/S2213-8587(20)30152-2 | pmc=7180013 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32334646  }}</ref>
  
 
==Classification==
 
==Classification==
 +
<br />
 
==Pathophysiology==
 
==Pathophysiology==
  
 
*
 
*
 +
 +
* [[COVID-19]] is caused by a [[virus]] named [[SARS-CoV-2|severe acute respiratory syndrome coronavirus-2]] ([[SARS-CoV-2]]) belong to the order [[Nidovirales|nidovirale]], family [[coronaviridae]][[COVID-19|.]]
  
 
==Causes==
 
==Causes==

Revision as of 20:09, 2 August 2020

WikiDoc Resources for COVID-19 in Diabetics

Articles

Most recent articles on COVID-19 in Diabetics

Most cited articles on COVID-19 in Diabetics

Review articles on COVID-19 in Diabetics

Articles on COVID-19 in Diabetics in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on COVID-19 in Diabetics

Images of COVID-19 in Diabetics

Photos of COVID-19 in Diabetics

Podcasts & MP3s on COVID-19 in Diabetics

Videos on COVID-19 in Diabetics

Evidence Based Medicine

Cochrane Collaboration on COVID-19 in Diabetics

Bandolier on COVID-19 in Diabetics

TRIP on COVID-19 in Diabetics

Clinical Trials

Ongoing Trials on COVID-19 in Diabetics at Clinical Trials.gov

Trial results on COVID-19 in Diabetics

Clinical Trials on COVID-19 in Diabetics at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on COVID-19 in Diabetics

NICE Guidance on COVID-19 in Diabetics

NHS PRODIGY Guidance

FDA on COVID-19 in Diabetics

CDC on COVID-19 in Diabetics

Books

Books on COVID-19 in Diabetics

News

COVID-19 in Diabetics in the news

Be alerted to news on COVID-19 in Diabetics

News trends on COVID-19 in Diabetics

Commentary

Blogs on COVID-19 in Diabetics

Definitions

Definitions of COVID-19 in Diabetics

Patient Resources / Community

Patient resources on COVID-19 in Diabetics

Discussion groups on COVID-19 in Diabetics

Patient Handouts on COVID-19 in Diabetics

Directions to Hospitals Treating COVID-19 in Diabetics

Risk calculators and risk factors for COVID-19 in Diabetics

Healthcare Provider Resources

Symptoms of COVID-19 in Diabetics

Causes & Risk Factors for COVID-19 in Diabetics

Diagnostic studies for COVID-19 in Diabetics

Treatment of COVID-19 in Diabetics

Continuing Medical Education (CME)

CME Programs on COVID-19 in Diabetics

International

COVID-19 in Diabetics en Espanol

COVID-19 in Diabetics en Francais

Business

COVID-19 in Diabetics in the Marketplace

Patents on COVID-19 in Diabetics

Experimental / Informatics

List of terms related to COVID-19 in Diabetics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification


Pathophysiology

Causes

Disease name] may be caused by [cause1], [cause2], or [cause3].

Differentiating [disease name] from other Diseases

  • [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

Epidemiology and Demographics

  • The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.

Age

  • Patients of all age groups may develop [disease name].

Gender

  • [Disease name] affects men and women equally.

Race

  • There is no racial predilection for [disease name].

Risk Factors

  • Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

  • The majority of patients with [disease name] remain asymptomatic for [duration/years].

Diagnosis

History and Symptoms

  • [Disease name] is usually asymptomatic.
  • Symptoms of [disease name] may include the following:

Physical Examination

  • Patients with [disease name] usually appear [general appearance].
  • Physical examination may be remarkable for:

Laboratory Findings

  • There are no specific laboratory findings associated with [disease name].

Electrocardiogram

There are no ECG findings associated with [disease name].

X-ray

There are no x-ray findings associated with [disease name].

Echocardiography or Ultrasound

There are no echocardiography/ultrasound findings associated with [disease name].

CT scan

There are no CT scan findings associated with [disease name].

MRI

There are no MRI findings associated with [disease name].

Other Imaging Findings

There are no other imaging findings associated with [disease name].

Other Diagnostic Studies

There are no other diagnostic studies associated with [disease name].

Treatment

Medical Therapy

  • The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
  • Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

Prevention

  • There are no primary preventive measures available for [disease name].

References

  1. Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL; et al. (2020). "Practical recommendations for the management of diabetes in patients with COVID-19". Lancet Diabetes Endocrinol. 8 (6): 546–550. doi:10.1016/S2213-8587(20)30152-2. PMC 7180013 Check |pmc= value (help). PMID 32334646 Check |pmid= value (help).